Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis

Journal of Urology

Volumn 194, Issue 2, 2015, Pages 378-385

  Satkunasivam, Raj ^a   Kim, Andre E ^b   Desai, Mihir ^a   Nguyen, Mike M ^a   Quinn, David I ^a   Ballas, Leslie ^a   Lewinger, Juan Pablo ^b   Stern, Mariana C ^b   Hamilton, Ann S ^b   Aron, Monish ^a   Gill, Inderbir S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

intensity modulated; mortality; prostatectomy; prostatic neoplasms; radiotherapy; SEER program

Indexed keywords

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; DEMOGRAPHY; DISEASE SPECIFIC SURVIVAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; SURVIVAL TIME; BRACHYTHERAPY; CANCER REGISTRY; MEDICARE; MIDDLE AGED; MORTALITY; PROCEDURES; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TRENDS; UNITED STATES;

AGED; BRACHYTHERAPY; HUMANS; MALE; MEDICARE; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84943350420     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.02.084     Document Type: Article

References (28)

1. M. Hussain, C.M. Tangen, D.L. Berry, and et al. Intermittent versus continuous androgen deprivation in prostate cancer N Engl J Med 368 2013 1314
2. D.A. Loblaw, K.S. Virgo, R. Nam, and et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline J Clin Oncol 25 2007 1596
3. I.M. Thompson, C. Tangen, J. Basler, and et al. Impact of previous local treatment for prostate cancer on subsequent metastatic disease J Urol 168 2002 1008
4. S.H. Culp, P.F. Schellhammer, and M.B. Williams Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study Eur Urol 65 2014 1058
5. S. Antwi, and T.M. Everson Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: a population-based, propensity score analysis Cancer Epidemiol 38 2014 435
6. N. Fossati, Q.D. Trinh, J. Sammon, and et al. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study Eur Urol 67 2015 3
7. B.F. Hankey, L.A. Ries, and B.K. Edwards The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiol Biomarkers Prev 8 1999 1117
8. J.L. Warren, C.N. Klabunde, D. Schrag, and et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3
9. S.T. Fleming, A.S. Hamilton, S.A. Sabatino, and et al. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review Med Care 52 2014 e58
10. G.H. Goldin, N.C. Sheets, A.M. Meyer, and et al. Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy JAMA Intern Med 173 2013 1136
11. M.G. Cameron, C. Kersten, M.G. Guren, and et al. Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - a systematic review Radiother Oncol 110 2014 55
12. J.S.Y. Wu, R. Wong, M. Johnston, and et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases Int J Radiat Oncol Biol Phys 55 2003 594
13. S.G. Ellsworth, S.R. Alcorn, R.K. Hales, and et al. Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution Int J Radiat Oncol Biol Phys 89 2014 1100
14. A.M. Noone, J.L. Lund, A. Mariotto, and et al. Comparison of SEER treatment data with Medicare claims Med Care 2014 Epub ahead of print
15. J.C. Hu, X. Gu, S.R. Lipsitz, and et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy JAMA 302 2009 1557
16. C.B. Roberts, T.L. Jang, Y.H. Shao, and et al. Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based study Prostate Cancer Prostatic Dis 14 2011 313
17. C.N. Klabunde, A.L. Potosky, J.M. Legler, and et al. Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258
18. V.B. Shahinian, Y.F. Kuo, J.L. Freeman, and et al. Risk of fracture after androgen deprivation for prostate cancer N Engl J Med 352 2005 154
19. P.C. Austin An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivariate Behav Res 46 2011 399
20. S.D. Berry, L. Ngo, E.J. Samelson, and et al. Competing risk of death: an important consideration in studies of older adults J Am Geriatr Soc 58 2010 783
21. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496
22. M.M. Nguyen, and I.S. Gill Coded tumor size may be unreliable for small metastatic renal cancers in the Surveillance, Epidemiology, and End Results dataset Urology 75 2010 266
23. P. Stattin, and S. Loeb "To measure is to know. If you cannot measure it, you cannot improve it": statistical modeling cannot compensate for unmeasured bias Eur Urol 65 2014 701
24. A. Heidenreich, D. Pfister, and D. Porres Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study J Urol 193 2015 832
25. B. Psaila, and D. Lyden The metastatic niche: adapting the foreign soil Nat Rev Cancer 9 2009 285
26. M.Y. Kim, T. Oskarsson, S. Acharyya, and et al. Tumor self-seeding by circulating cancer cells Cell 139 2009 1315
27. T. Stoyanova, A.R. Cooper, J.M. Drake, and et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells Proc Natl Acad Sci U S A 110 2013 20111
28. V. Tzelepi, E. Efstathiou, S. Wen, and et al. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment J Clin Oncol 29 2011 2574